Pabalan Noel, Singh Neetu, Pineda Maria Ruth, Jarjanazi Hamdi
School of Natural Sciences and Nursing, Saint Louis University, 2600, Baguio City, Philippines.
J Gastrointest Cancer. 2014 Sep;45(3):319-24. doi: 10.1007/s12029-014-9608-9.
Inconsistency of reported associations of the G/A polymorphism (rs2301756) in the PTPN11 gene and gastric atrophy prompted us to undertake a meta-analysis.
We searched PubMed for published literature up to July 2013. Individual data from studies with case-control design were evaluated for the PTPN11 G/A polymorphism in Helicobacter pylori (-) (seronegative) and (+) (seropositive) subjects (four studies each, totaling 3,597 cases and 4,865 controls).
Associations of PTPN11 polymorphism with gastric atrophy in H. pylori (-) and (+) subjects are more readily interpreted in the homozygous and recessive models given that the dominant codominant effects skirted null associations. Thus, homozygous and recessive effects indicated reduced risk [odds ratio (OR) 0.92-0.96, p = 0.51-0.74], which is significant among H. pylori (+) subjects (OR 0.66-0.68, p = 0.04-0.05). Confined to the Japanese, reduced risk effects were unaltered in both groups, less protective among seronegative subjects (OR 0.85-0.86, p = 0.71-0.73) than seropositive subjects with significance in the recessive model (OR 0.67, p = 0.05). Sensitivity analysis demonstrated robustness of the seropositive findings, but probably not the seronegative results where homozygous and recessive pooled ORs were altered from protection to increased risk.
Evidence of overall and subgroup decreased risks, strong in seropositive subjects, demonstrates protective effects of the PTPN11 G/A polymorphism from gastric atrophy.
PTPN11基因中G/A多态性(rs2301756)与胃萎缩的关联报道存在不一致性,促使我们进行一项荟萃分析。
我们在PubMed上检索截至2013年7月的已发表文献。对病例对照设计研究中的个体数据进行评估,分析幽门螺杆菌(-)(血清阴性)和(+)(血清阳性)受试者的PTPN11 G/A多态性(每项研究各4项,共3597例病例和4865例对照)。
鉴于显性共显性效应接近无效关联,在纯合子和隐性模型中,PTPN11多态性与幽门螺杆菌(-)和(+)受试者胃萎缩的关联更容易解释。因此,纯合子和隐性效应表明风险降低[比值比(OR)0.92 - 0.96,p = 0.51 - 0.74],这在幽门螺杆菌(+)受试者中具有显著性(OR 0.66 - 0.68,p = 0.04 - 0.05)。在日本人中,两组的风险降低效应均未改变,血清阴性受试者(OR 0.85 - 0.86,p = 0.71 - 0.73)的保护作用低于血清阳性受试者,在隐性模型中具有显著性(OR 0.67,p = 0.05)。敏感性分析表明血清阳性结果具有稳健性,但血清阴性结果可能并非如此,其中纯合子和隐性合并OR从保护作用变为风险增加。
总体和亚组风险降低的证据在血清阳性受试者中较强,表明PTPN11 G/A多态性对胃萎缩具有保护作用。